Overview
Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor
Status:
Completed
Completed
Trial end date:
2017-03-01
2017-03-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study is to determine efficacy of vaginal and oral progesterone after tocolytic therapy in threatened preterm laborPhase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Sanpasitthiprasong HospitalTreatments:
Dydrogesterone
Progesterone
Tocolytic Agents
Criteria
Inclusion Criteria:- Single pregnancies of 28 to 33 weeks and 6 days who had been experienced for
threatened or preterm labor with intact membrane
Exclusion Criteria:
- Proven membranes ruptured
- Ultrasonographically found placenta previa, multiple pregnancy, fetal anomaly
- Aneuploidy detected.
- Had emergency condition that required for emergency delivery such as fetal distress,
chorioamnionitis, prolapsed cord